Growth factors in clinical practice

Related Experiment Video

Updated: Oct 9, 2026

Visualizing Angiogenesis by Multiphoton Microscopy In Vivo in Genetically Modified 3D-PLGA/nHAp Scaffold for Calvarial Critical Bone Defect Repair
09:34

Visualizing Angiogenesis by Multiphoton Microscopy In Vivo in Genetically Modified 3D-PLGA/nHAp Scaffold for Calvarial Critical Bone Defect Repair

Published on: September 7, 2017

G B Köveker1

  • 1Department of General Surgery, City Hospital of Sindelfingen, Germany.

International Journal of Clinical Practice
|February 28, 2001
PubMed

Insights

Growth factors are key to wound healing. Recombinant human platelet-derived growth factor-BB (rhPDGF-BB) shows promise in treating chronic diabetic foot ulcers, improving healing rates and time.

Area of Science:

  • Biochemistry
  • Cellular Biology
  • Wound Healing Research

Background:

  • Wound repair involves complex cellular and biochemical interactions regulated by growth factors.
  • Chronic wounds often exhibit impaired healing, potentially due to diminished growth factor levels or increased degradation.
  • Topical growth factor application shows potential in animal models for wound healing.

Purpose of the Study:

  • To investigate the role of growth factors in wound repair.
  • To evaluate the efficacy of recombinant human platelet-derived growth factor-BB (rhPDGF-BB) in promoting wound healing.
  • To assess the impact of rhPDGF-BB on diabetic foot ulcers.

Main Methods:

  • Review of existing literature on growth factors in wound healing.
  • Analysis of studies involving topical application of growth factors.
  • Examination of clinical trial data for rhPDGF-BB in diabetic foot ulcer patients.

Main Results:

  • Platelet-derived growth factor-BB (PDGF-BB) promotes granulation tissue formation and epithelialization.
  • Clinical trials with rhPDGF-BB demonstrated significant improvements in healing rate and time for diabetic foot ulcers.
  • rhPDGF-BB is the most investigated growth factor in human wound healing studies.

Conclusions:

  • rhPDGF-BB is a promising therapeutic agent for chronic wound management, particularly diabetic foot ulcers.
  • Further refinement of growth factor-based therapeutic strategies is anticipated for future wound healing treatments.
  • Understanding growth factor dynamics is crucial for addressing impaired wound healing mechanisms.

Related Concept Videos

Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...